A61K 47/557
The modifying agent being biotin
Official title: {the modifying agent being biotin}
A61K47/557 (The modifying agent being biotin) appears on 111 US grants and 144 published applications in this corpus.
Search patents in A61K- Granted patents
- 111
- Published applications
- 144
- Assignees
- 110
- Inventors
- 314
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 3 | 0 |
| 1999 | 6 | 0 |
| 2000 | 3 | 0 |
| 2001 | 4 | 0 |
| 2002 | 4 | 4 |
| 2003 | 3 | 6 |
| 2004 | 3 | 5 |
| 2005 | 2 | 5 |
| 2006 | 1 | 6 |
| 2007 | 3 | 3 |
| 2008 | 1 | 4 |
| 2009 | 4 | 6 |
| 2010 | 2 | 13 |
| 2011 | 0 | 4 |
| 2012 | 5 | 1 |
| 2013 | 3 | 6 |
| 2014 | 4 | 6 |
| 2015 | 0 | 7 |
| 2016 | 6 | 5 |
| 2017 | 2 | 4 |
| 2018 | 7 | 7 |
| 2019 | 5 | 9 |
| 2020 | 6 | 6 |
| 2021 | 6 | 9 |
| 2022 | 4 | 5 |
| 2023 | 1 | 8 |
| 2024 | 5 | 7 |
| 2025 | 0 | 4 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Microbubble-chemotherapeutic agent complex for sonodynamic therapy26 May 2026US 12,636,379 B2Sonotarg Limited
- Cationic nanostructures for intra-cartilage delivery of contrast agents and diagnostic uses thereof3 Mar 2026US 12,564,639 B2Northeastern University
- Multiple antigen presenting immunogenic composition, and methods and uses thereof10 Feb 2026US 12,545,710 B2Children's Medical Center Corporation
- Method for isolating and detecting cancer stem cells8 Oct 2024US 12,109,248 B2
- Molecular vaccines for infectious disease28 May 2024US 11,992,518 B2Agilent Technologies, Inc.
- Universal abt compounds and uses thereof24 Sep 2026US 2026/0284204 A1Kleo Pharmaceuticals, Inc.
- Modified biotin-binding protein, fusion proteins thereof and applications10 Sep 2026US 2026/0265313 A1Children's Medical Center Corporation
- Cd4 + and cd8 + single positive t cells and compositions and methods for generating the same20 Aug 2026US 2026/0242728 A1Clade Therpaeutics, Inc.
- Lipid construct for delivery of insulin to a mammal7 May 2026US 2026/0124139 A1
- Use of gsmtx4 and gsmtx4 conjugates to improve recovery from joint injury18 Sep 2025US 2025/0288645 A1The Research Foundation for The State University of New York
Most cited
By later US patents
- Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof518US 5,550,111 ATemple University of the Commonwealth System of Higher Education · 1996
- Method for enhancing transmembrane transport of exogenous molecules352US 5,416,016 APurdue Research Foundation · 1995
- Method for enhanced transmembrane transport of exogenous molecules302US 5,108,921 APurdue Research Foundation · 1992
- Pretargeting methods and compounds125US 6,217,869 B1NeoRx Corporation · 2001
- Composition and method for tumor imaging123US 5,688,488 APurdue Research Foundation · 1997